Boca Raton, FL (PRWEB) April 10, 2015
Wimbledon Health Partners, the leading on-site diagnostic testing organization which provides vascular, electrocardiogram, echocardiogram, and NCV testing, is proud to announce the roll-out of Wimbledon Athletics, a division specifically focused on preventing sudden cardiac death among school-age athletes.
“Wimbledon Athletics is a much needed program for this audience,” says Bradley Artel, M.D., F.A.C.C. Chief Medical Officer of Wimbledon Health Partners. “The incidence of sudden cardiac death (SCD) involving high school and college athletes has been gaining more attention, and it’s important we don’t neglect the younger athlete. There is now evidence that the prevalence of hypertrophic cardiomyopathy (HCM) may be as great as 1 in 200 individuals.”
The diagnostic tests performed by the Wimbledon Athletics division, include a non-invasive vascular ultrasound, electrocardiogram (EKG), and echocardiogram (echo) testing. In combination, these tests can identify underlying signs of hypertrophic cardiomyopathy – the leading cause of death among young athletes, and Marfan Syndrome, which can also represent an asymptomatic risk for death.
On-site diagnostic testing is convenient for athletes because appointments are booked around training schedules, and testing is performed in familiar surroundings – minimizing stress and anxiety. Most importantly, athletes know that their risk for sudden cardiac death is low, and they are ready to safely compete.
Wimbledon Athletics will team up with high schools, amateur sport associations, and any other clubs nationwide that want to ensure the heart health of their athletes. Wimbledon Athletics is quickly becoming the provider of choice. For more information, or to learn how to bring on-site diagnostic testing to your team, please call (855) 200-8262 or visit http://www.dxtesting.com.
About Wimbledon Health Partners:
Wimbledon Health Partners was formed in response to the demand to attain on-site diagnostic testing capabilities for circulatory conditions that can be detected through the use of vascular ultrasound and echocardiography. Furthering our capabilities, nerve conduction velocity testing (NCV) is also utilized to support diagnosis of nerve involvement and manage risk. The company also reinforces its mission of promoting early testing through its collegiate testing division, Wimbledon U, specifically focusing on underlying symptoms related to arterial diseases to help minimize death among young athletes. Wimbledon Health Partners is an innovative cooperative marketing and practice-enhancement program that provides physicians with the educational, compliance, and marketing tools necessary to provide quality, state-of-the-art, in-office testing procedures. For more information go to http://www.dxtesting.com or call (855) 200-8262.